A Phase I Study of Methoxyamine and Temozolomide in Patients With Advanced Solid Tumours

Trial Profile

A Phase I Study of Methoxyamine and Temozolomide in Patients With Advanced Solid Tumours

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs TRC 102 (Primary) ; Temozolomide
  • Indications Solid tumours
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 26 Jul 2017 Status changed from active, no longer recruiting to completed.
    • 18 May 2017 According to a Tracon Pharmaceuticals media release, data from expanded cohorts of this trial will be presented by the National Cancer Institute at ASCO in June 2017.
    • 28 Feb 2017 According to a Tracon Pharmaceuticals media release, presentation of data from expanded cohorts of this trial expected in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top